← All trials
NCT00005009
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 1998
- Primary completion
- Jun 16, 2001
- Completion date
- Jun 16, 2001
- First posted
- —
- Last posted
- —
- Enrollment
- 7
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- National Institute of Allergy and Infectious Diseases (NIAID)Lead sponsor
- University of CincinnatiStudy chair
- North American Pediatric Renal Transplantation Study (NAPRTCS)Study chair
- MerckCollaborator
- Cooperative Clinical Trials in Pediatric TransplantationCollaborator
- National Institutes of Health (NIH)Collaborator
- North American Pediatric Renal Transplantation Study (NAPRTCS)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.